# SFI · Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System

_ ·  · Class 3_

**Canonical URL:** https://fda.innolitics.com/productcode/SFI

## Overview

- **Product Code:** SFI
- **Device Name:** Sensor, Glucose, Invasive, Component Of Automated Insulin Delivery System
- **Regulation:** 21 CFR N/A
- **Device Class:** 3
- **Review Panel:** [](/submissions/)

## Identification

The device is intended to measure glucose in interstitial fluid. It is intended to provide those measurements as inputs to appropriately qualified digitally connected devices, including automated insulin dosing systems, as determined by FDA.

## Recent Cleared Devices (1 of 1)

| Record | Device Name | Applicant | Decision Date | Decision |
| --- | --- | --- | --- | --- |
| [P250012](/device/P250012.md) | Simplera Sync Sensor, Guardian 4 Sensor | Medtronic Minimed, Inc. | Aug 6, 2025 | APPR |

## Top Applicants

- Medtronic Minimed, Inc. — 1 clearance

---

**Source:** [https://fda.innolitics.com/productcode/SFI](https://fda.innolitics.com/productcode/SFI)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com